Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.

Wharton, Sean, Astrup, Arne, Endahl, Lars, Lean, Michael EJ, Satylganova, Altynai, Skovgaard, Dorthe, Wadden, Thomas A and Wilding, John PH ORCID: 0000-0003-2839-8404
(2021) Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data. INTERNATIONAL JOURNAL OF OBESITY, 45 (5). 923 - 933.

O'Neil, Patrick M, Aroda, Vanita R, Astrup, Arne, Kushner, Robert, Lau, David CW, Wadden, Thomas A, Brett, Jason, Cancino, Ana-Paula, Wilding, John PH ORCID: 0000-0003-2839-8404 and Adiposity, Satiety Clinical
(2017) Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials. DIABETES OBESITY & METABOLISM, 19 (11). 1529 - 1536.

Wilding, John PH ORCID: 0000-0003-2839-8404, Batterham, Rachel L, Calanna, Salvatore, Davies, Melanie, Van Gaal, Luc F, Lingvay, Ildiko, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie TD, Wadden, Thomas A
et al (show 5 more authors) (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEW ENGLAND JOURNAL OF MEDICINE, 384 (11). 989 - 1002.

Kushner, Robert F, Calanna, Salvatore, Davies, Melanie, Dicker, Dror, Garvey, W Timothy, Goldman, Bryan, Lingvay, Ildiko, Thomsen, Mette, Wadden, Thomas A, Wharton, Sean
et al (show 2 more authors) (2020) Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. OBESITY, 28 (6). 1050 - 1061.

This list was generated on Sun May 9 04:07:27 2021 BST.